AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 683221-00-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
3-Amino-3-[3-(Trifluoromethyl)Phenyl]Propan-1-Ol
Also known as: 683221-00-3, 3-amino-3-(3-trifluoromethyl-phenyl)-propan-1-ol, 3-amino-3-[3-(trifluoromethyl)phenyl]-1-propanol, Bionet2_001406, Schembl381257, Hms1367p20
Molecular Formula
C10H12F3NO
Molecular Weight
219.20  g/mol
InChI Key
AITWXNLDCLFQPJ-UHFFFAOYSA-N

1 2D Structure

3-Amino-3-[3-(Trifluoromethyl)Phenyl]Propan-1-Ol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-amino-3-[3-(trifluoromethyl)phenyl]propan-1-ol
2.1.2 InChI
InChI=1S/C10H12F3NO/c11-10(12,13)8-3-1-2-7(6-8)9(14)4-5-15/h1-3,6,9,15H,4-5,14H2
2.1.3 InChI Key
AITWXNLDCLFQPJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC(=C1)C(F)(F)F)C(CCO)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 683221-00-3

2. 3-amino-3-(3-trifluoromethyl-phenyl)-propan-1-ol

3. 3-amino-3-[3-(trifluoromethyl)phenyl]-1-propanol

4. Bionet2_001406

5. Schembl381257

6. Hms1367p20

7. Mfcd03412708

8. Akos011675178

9. Cs-0238934

10. Sr-01000306981

11. 10w-0861

12. Sr-01000306981-1

2.3 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 219.20 g/mol
Molecular Formula C10H12F3NO
XLogP31.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass219.08709849 g/mol
Monoisotopic Mass219.08709849 g/mol
Topological Polar Surface Area46.2 Ų
Heavy Atom Count15
Formal Charge0
Complexity196
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
3886-70-2
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

78th STLE Annual Meeting

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY